No Data
No Data
Weigao Co., Ltd. (01066): Weigao Orthopedic (688161.SH)'s net profit of 34.9057 million yuan in the first quarter decreased by 62.92% year-on-year
Weigao Co., Ltd. (01066) announced Weigao Orthopedic (688161.SH) results for the first quarter of 2024, business...
League of Nations Securities: The impact of collection is gradually clear, and the localization rate of the orthopedic industry continues to rise
Orthopedics is expected to usher in restorative growth
Guoxin Securities released a research report on April 9 stating that it gave Weigao Orthopedic (688161.SH) an increase in its holdings. The main reasons for the rating include: 1) the 2023 performance was affected by falling factory prices and channel inv
Guoxin Securities released a research report on April 9 stating that it gave Weigao Orthopedic (688161.SH) an increase in its holdings. The main reasons for the rating include: 1) the 2023 performance was affected by falling factory prices and channel inventory compensation due to volume procurement execution; 2) revenue from each business line was under varying degrees of pressure, and sports medicine and tissue repair products became an important source of revenue; 3) gross net margin declined, and sales and R&D expenses increased significantly; 4) R&D investment remained high, and many products were in the registration stage. (Mainichi Keizai Shimbun)
Weigao Orthopedics (688161) 2023 Performance Review: Short-term performance is under pressure, the company actively optimizes product structure
Incident: The company released its annual results report for the year 23, achieving revenue of 1,284 billion yuan (-37.6%) for the whole year, achieving net profit of 112 million yuan (-81.3%) attributable to shareholders of listed companies, and deducting non-recurring profit and loss
Weigao Orthopedics (688161) Science and Technology Innovation Board Company Dynamic Research: Gathering gaps ended, performance entered an upward channel
Incident: On March 27, 2024, Weigao Orthopedic issued the 2023 annual results announcement: The company achieved revenue of 1,284 billion yuan in 2023, a year-on-year decrease of 37.63%. Achieved net profit of 112 million yuan to mother
Earnings Troubles May Signal Larger Issues for Shandong Weigao Orthopaedic Device (SHSE:688161) Shareholders
The subdued market reaction suggests that Shandong Weigao Orthopaedic Device Co., Ltd's (SHSE:688161) recent earnings didn't contain any surprises. However, we believe that investors should be aware
No Data